Effect of Percutaneous Transluminal Angioplasty on the Stenosis of Autogenous Radiocephalic Arteriovenous Fistula for Hemodialysis

• Published in: Taehan Yŏngsang Ŭihakhoe chi Vol. 74; no. 2; pp. 105 - 113
• Main Authors: Sun Min Jeong, Jeong Ho Kim, Sung Su Byun, Jin Mo Kang, Sang Tae Choi, Jong Woo Kim, Hyung Sik Kim, Hye Young Choi, Jae Hyung Park
• Format: Journal Article
• Language: English
• Published: The Korean Society of Radiology 01.02.2016
• Subjects: arteriovenous fistula; complications; percutaneous transluminal angioplasty; stenosis; vascular patency
• ISSN: 1738-2637; 2288-2928
• DOI: 10.3348/jksr.2016.74.2.105

Purpose The purpose of this study was to evaluate the effectiveness of percutaneous transluminal angioplasty (PTA) on stenosis of autogenous radiocephalic arteriovenous fistula (RCF) for hemodialysis and to determine the factors influencing patency. Materials and Methods This retrospective study included 136 patients referred for PTA of RCF stenosis between March 2005 and July 2014. The technical success rate, complications, and patency rate were evaluated. The following factors were analyzed as they might influence patency: age, gender, site and duration of arteriovenous fistula, underlying disease, body mass index, hypercholesterolemia, smoking, peripheral artery or coronary artery occlusive disease, stenosis length/grade, cutting balloon, and balloon size. Results The initial technical success rate was 91.9% (125/136). Complications included vessel rupture (n = 2) and vessel dissection (n = 2). The patency rates at 6, 12, 24, and 48 months after PTA were 81.9, 67.1, 52.7, and 42.3%, respectively. The patency rate was higher in cases with longer (> 3 cm) stenosis (p = 0.04). Use of cutting balloon and larger size of balloon catheter made the patency longer, but this difference was not statistically significant (p = 0.637, 0.258). Conclusion PTA is a safe and effective way to manage stenosis in RCF. The length of stenosis was the only factor which affected the patency rate in this study.